ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975